RTI-229

Source: Wikipedia, the free encyclopedia.

RTI-229
Legal status
Legal status
  • In general: legal
Identifiers
  • [(1R,2S,3S,5S)-3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl]-pyrrolidin-1-ylmethanone
JSmol)
  • CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)C3=CC=C(C=C3)I)C(=O)N4CCCC4
  (verify)

RTI-229, also known as (–)-3β-(4-iodophenyl)tropane-2β-pyrrolidine carboxamide and RTI-4229-229, is a potent and long-lasting

NET and 5-HTT respectively) and is one of the most DAT-selective compounds in the RTI series.[1][2]

Uses

RTI-229 is mainly used in scientific research into the dopamine reuptake transporter, with its extremely high DAT selectivity making it useful for distinguishing between DAT and NET binding sites in the brain to an even greater extent than related compounds such as RTI-121.[3]

Legal Status

RTI-229 is legal throughout the world as of 2010. Some jurisdictions such as the United States, Australia and New Zealand might however consider RTI-229 to be a

controlled substance analogue of cocaine
on the grounds of its related chemical structure.

See also

References

  1. PMID 7830281
    .
  2. PMID 11749256
    .
  3. doi:10.1002/(sici)1099-1344(199903)42:3<281::aid-jlcr188>3.3.co;2-o
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=RTI-229&oldid=1209742437"